Automatic Generation of Validated Specific Epitope Sets

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Pro, Sebastian Carrasco ^a,b   Sidney, John ^b   Paul, Sinu ^b   Arlehamn, Cecilia Lindestam ^b   Weiskopf, Daniela ^b   Peters, Bjoern ^b   Sette, Alessandro ^b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRAL PROTEIN;

ARTICLE; AUTOIMMUNITY; AUTOMATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CLASSIFICATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE VIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREACTIVITY; IN VITRO STUDY; LATENT TUBERCULOSIS; LEUKAPHERESIS; MOLECULAR RECOGNITION; MYCOBACTERIUM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; CELL CULTURE; EPITOPE MAPPING; FACTUAL DATABASE; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; IMMUNOTHERAPY; INFORMATION PROCESSING; LYMPHOCYTE ACTIVATION; METABOLISM; MYCOBACTERIACEAE; PERSONALIZED MEDICINE; PROCEDURES; SOFTWARE;

AUTOMATIC DATA PROCESSING; CELLS, CULTURED; DATABASES, FACTUAL; DENGUE VIRUS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC TESTS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MYCOBACTERIACEAE; PRECISION MEDICINE; SOFTWARE; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 84947087515     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/763461     Document Type: Article

References (25)

1. D. R. Madden, "The three-dimensional structure of peptide-MHC complexes," Annual Review of Immunology, vol. 13, pp. 587-622, 1995.
2. J. Neefjes, M. L. M. Jongsma, P. Paul, and O. Bakke, "Towards a systems understandingofMHCclass i andMHCclass II antigen presentation," Nature Reviews Immunology, vol. 11, no. 12, pp. 823-836, 2011.
3. C. Kurts, B. W. Robinson, and P. A. Knolle, "Cross-priming in health and disease," Nature Reviews Immunology, vol. 10, no. 6, pp. 403-414, 2010.
4. L. Borish, "Genetics of allergy and asthma," Annals of Allergy, Asthma & Immunology, vol. 82, no. 5, pp. 413-426, 1999.
5. J.-M.Andrieu,S.Chen, C. Lai,W.Guo, andW.Lu, "Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8+ T-regulatory cells that suppress SIVpositive CD4+ T-cell activation and prevent SIV infection in themacaque model," Frontiers in Immunology, vol. 5, article 297, 2014.
6. J. Patterson-Bartlett, M. J. Levin, N. Lang, F. P. Schödel, R. Vessey, and A. Weinberg, "Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine," Vaccine, vol. 25, no. 41, pp. 7087-7093, 2007.
7. T. Prezzemolo, G. Guggino, M. P. la Manna, D. D. di Liberto, F. Dieli, and N. Caccamo, "Functional signatures of human CD4 and CD8 T cell responses toMycobacterium tuberculosis," Frontiers in Immunology, vol. 5, article 180, 2014.
8. A. Sette and R. Rappuoli, "Reverse vaccinology: developing vaccines in the era of genomics," Immunity, vol. 33, no. 4, pp. 530-541, 2010.
9. C. Leisner, N. Loeth, K. Lamberth et al., "One-pot, mix-andread peptide-MHC tetramers," PLoS ONE, vol. 3, no. 2, Article ID e1678, 2008.
10. P. Braendstrup, B. K. Mortensen, S. Justesen et al., "Identification andHLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2," PLoS ONE, vol. 9, no. 4, Article IDe94892, 2014.
11. D. Weiskopf, M. A. Angelo, E. L. De Azeredo et al., "Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 22, pp. E2046-E2053, 2013.
12. C. Oseroff, J. Sidney, M. F. Kotturi et al., "Molecular determinants of T cell epitope recognition to the common Timothy grass allergen," Journal of Immunology, vol. 185, no. 2, pp. 943-955, 2010.
13. R. Vita, L. Zarebski, J. A. Greenbaum et al., "The immune epitope database 2.0," Nucleic Acids Research, vol. 38, no. 1, Article ID gkp1004, pp. D854-D862, 2009.
14. R. Vita, J. A. Overton, J. A. Greenbaum et al., "The immune epitope database (IEDB) 3.0,"Nucleic Acids Research, vol. 43,pp. D405-D412, 2015.
15. E. J. Novak, A. W. Liu, J. A. Gebe et al., "Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens," Journal of Immunology, vol. 166, no. 11, pp. 6665-6670, 2001.
16. C. L. Day, N. P. Seth,M. Lucas et al., "Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers,"The Journal of Clinical Investigation, vol. 112, no. 6, pp. 831-842, 2003.
17. W.W.Kwok,M. Roti, J.H.DeLong et al., "Direct ex vivo analysis of allergen-specific CD4+ T cells," Journal of Allergy and Clinical Immunology, vol. 125, no. 6, pp. 1407.e1-1409.e1, 2010.
18. Y. Kim, K. Vaughan, J. Greenbaum, B. Peters, M. Law, and A. Sette, "A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV)," PLoS ONE, vol. 7, no. 5, Article ID e38028, 2012.
19. A. Bresciani, J. Greenbaum, C. S. L. Arlehamn, A. Sette, M. Nielsen, and B. Peters, "The interplay of sequence conservation and T cell immune recognition," in Proceedings of the 5th ACMConference on Bioinformatics, Computational Biology, and Health Informatics (BCB '14), pp. 739-743, Newport Beach, Calif, USA, September 2014.
20. R. de Alwis and A. M. de Silva, "Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique," Methods in Molecular Biology, vol. 1138, pp. 27-39, 2014.
21. E. Seymour, R. Damle, A. Sette, and B. Peters, "Cost sensitive hierarchical document classification to triage PubMed abstracts for manual curation," BMC Bioinformatics, vol. 12, no. 1, article 482, 2011.
22. V. Davies, K. Vaughan, R. Damle, B. Peters, and A. Sette, "Classification of the universe of immune epitope literature: representation and knowledge gaps," PLoS ONE, vol. 4, no. 9, Article ID e6948, 2009.
23. M. F. Kagnoff, "Celiac disease: pathogenesis of a model immunogenetic disease," The Journal of Clinical Investigation, vol. 117, no. 1, pp. 41-49, 2007.
24. H. Hjalgrim, J. Friborg, and M. Melbye, "The epidemiology of EBV and its association with malignant disease," in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, and R. Whitley, Eds., Cambridge University Press, Cambridge, UK, 2007.
25. C. S. Lindestam Arlehamn, S. Paul, F. Mele et al., "Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes," Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 2, pp. E147-E155, 2015.